Efficacy and safety of ACEI/ARB drug plus Yishenhuashi Granule: a Meta-analysis

Objective To systematically evaluate the efficacy and safety of Yishenhuashi Granule plus ACEI/ARB drug for chronic glomerulonephritis(CGN)and provide evidence-based references for clinical practices.Methods Randomized control trials(CTs)and quasi-randomized control trials(qRCTS)related to treating...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhao Qing, Zhen Min, Yang Yu-feng, Wu Yi-lian, Shu Wei
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Nephrology 2021-01-01
Series:Linchuang shenzangbing zazhi
Subjects:
Online Access:http://www.lcszb.com/thesisDetails?columnId=57902679&Fpath=home&index=0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849323600444653568
author Zhao Qing
Zhen Min
Yang Yu-feng
Wu Yi-lian
Shu Wei
author_facet Zhao Qing
Zhen Min
Yang Yu-feng
Wu Yi-lian
Shu Wei
author_sort Zhao Qing
collection DOAJ
description Objective To systematically evaluate the efficacy and safety of Yishenhuashi Granule plus ACEI/ARB drug for chronic glomerulonephritis(CGN)and provide evidence-based references for clinical practices.Methods Randomized control trials(CTs)and quasi-randomized control trials(qRCTS)related to treating CGN with Yishenhuashi Granule plus ACEI/ARB drug were collected from the databases of PubMed, Embase, Cochrane Library, CNKI,WangFang, VIP and CBM.The quality of included studies was evaluated and RewMAN 5.3 utilized for data analysis.Results Twenty eligible studies of 2885 cases were finally included.Meta-analysis indicated that Yishenhuashi Granule plus ACEI/ARB drug could improve clinical efficacy of CGN [OR=4.46,95%CI(3.45,5.76)] through reducing serum creatinine(Scr)(MD=-17.70,95%CI(-22.74,-12.66),P<0.01),urinary nitrogen(BUN)(MD=-1.67,95%CI(-1.89,-1.46),P<0.01),urinary protein quantification(24 hUTP)[MD=-0.41,95%CI(-0.45,-0.36)] and plasma albumin(Alb)[MD=2.34,95%CI(0.88,3.80)] without a greater incidence of adverse reactions.However, there was no obvious effect in lowering hematuria [MD=-1.71,95%CI(-4.38,0.86),P=0.19].Conclusions As compared with ACEI/ARB drug alone, Yishenhuashi Granule plus ACEI/ARB drug can improve overall effective rate and restore renal function.And more clinical proofs are required for further validation due to limited quantity/quality of included studies.
format Article
id doaj-art-e36451298a7c4edb9876a3502ec18a96
institution Kabale University
issn 1671-2390
language zho
publishDate 2021-01-01
publisher Editorial Department of Journal of Clinical Nephrology
record_format Article
series Linchuang shenzangbing zazhi
spelling doaj-art-e36451298a7c4edb9876a3502ec18a962025-08-20T03:48:58ZzhoEditorial Department of Journal of Clinical NephrologyLinchuang shenzangbing zazhi1671-23902021-01-012189590357902679Efficacy and safety of ACEI/ARB drug plus Yishenhuashi Granule: a Meta-analysisZhao QingZhen MinYang Yu-fengWu Yi-lianShu WeiObjective To systematically evaluate the efficacy and safety of Yishenhuashi Granule plus ACEI/ARB drug for chronic glomerulonephritis(CGN)and provide evidence-based references for clinical practices.Methods Randomized control trials(CTs)and quasi-randomized control trials(qRCTS)related to treating CGN with Yishenhuashi Granule plus ACEI/ARB drug were collected from the databases of PubMed, Embase, Cochrane Library, CNKI,WangFang, VIP and CBM.The quality of included studies was evaluated and RewMAN 5.3 utilized for data analysis.Results Twenty eligible studies of 2885 cases were finally included.Meta-analysis indicated that Yishenhuashi Granule plus ACEI/ARB drug could improve clinical efficacy of CGN [OR=4.46,95%CI(3.45,5.76)] through reducing serum creatinine(Scr)(MD=-17.70,95%CI(-22.74,-12.66),P<0.01),urinary nitrogen(BUN)(MD=-1.67,95%CI(-1.89,-1.46),P<0.01),urinary protein quantification(24 hUTP)[MD=-0.41,95%CI(-0.45,-0.36)] and plasma albumin(Alb)[MD=2.34,95%CI(0.88,3.80)] without a greater incidence of adverse reactions.However, there was no obvious effect in lowering hematuria [MD=-1.71,95%CI(-4.38,0.86),P=0.19].Conclusions As compared with ACEI/ARB drug alone, Yishenhuashi Granule plus ACEI/ARB drug can improve overall effective rate and restore renal function.And more clinical proofs are required for further validation due to limited quantity/quality of included studies.http://www.lcszb.com/thesisDetails?columnId=57902679&Fpath=home&index=0Yishenhuashi GranuleACEI/ARB drugchronic nephritisMeta-analysis
spellingShingle Zhao Qing
Zhen Min
Yang Yu-feng
Wu Yi-lian
Shu Wei
Efficacy and safety of ACEI/ARB drug plus Yishenhuashi Granule: a Meta-analysis
Linchuang shenzangbing zazhi
Yishenhuashi Granule
ACEI/ARB drug
chronic nephritis
Meta-analysis
title Efficacy and safety of ACEI/ARB drug plus Yishenhuashi Granule: a Meta-analysis
title_full Efficacy and safety of ACEI/ARB drug plus Yishenhuashi Granule: a Meta-analysis
title_fullStr Efficacy and safety of ACEI/ARB drug plus Yishenhuashi Granule: a Meta-analysis
title_full_unstemmed Efficacy and safety of ACEI/ARB drug plus Yishenhuashi Granule: a Meta-analysis
title_short Efficacy and safety of ACEI/ARB drug plus Yishenhuashi Granule: a Meta-analysis
title_sort efficacy and safety of acei arb drug plus yishenhuashi granule a meta analysis
topic Yishenhuashi Granule
ACEI/ARB drug
chronic nephritis
Meta-analysis
url http://www.lcszb.com/thesisDetails?columnId=57902679&Fpath=home&index=0
work_keys_str_mv AT zhaoqing efficacyandsafetyofaceiarbdrugplusyishenhuashigranuleametaanalysis
AT zhenmin efficacyandsafetyofaceiarbdrugplusyishenhuashigranuleametaanalysis
AT yangyufeng efficacyandsafetyofaceiarbdrugplusyishenhuashigranuleametaanalysis
AT wuyilian efficacyandsafetyofaceiarbdrugplusyishenhuashigranuleametaanalysis
AT shuwei efficacyandsafetyofaceiarbdrugplusyishenhuashigranuleametaanalysis